English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NA /

PY314-1-01

A Phase 1a/1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phae Ia/1b
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: